Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth hormone and malignancy.

G S Andrews

    Journal of Clinical Pathology
    |August 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Patients with secondary liver cancer showed significantly higher growth hormone levels than other cancer groups. This suggests altered liver metabolism, not tumor production, causes elevated growth hormone in liver metastases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Case of traumatic recto-vesical fistula.

    British medical journal·2010
    Same author

    Age differences in perceived social support by paediatric haematopoietic progenitor cell transplant patients: a longitudinal study.

    Child: care, health and development·2008
    Same author

    Reflections on a cytology screening service.

    Tumori·1980
    Same author

    Studies of plasma zinc, copper, caeruloplasmin, and growth hormone: with special reference to carcinoma of the bronchus.

    Journal of clinical pathology·1979
    Same author

    Pathologists' work load.

    British medical journal·1979
    Same author

    Zuckerman overtaken.

    British medical journal·1978
    Same journal

    Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

    Journal of clinical pathology·2026
    Same journal

    MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

    Journal of clinical pathology·2026
    Same journal

    Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

    Journal of clinical pathology·2026
    Same journal

    MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

    Journal of clinical pathology·2026
    Same journal

    Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

    Journal of clinical pathology·2026
    Same journal

    Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

    Journal of clinical pathology·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Oncology
    • Hepatology

    Background:

    • Elevated growth hormone (GH) levels can occur in various clinical conditions.
    • The relationship between malignancy, liver involvement, and GH concentrations requires further elucidation.

    Purpose of the Study:

    • To investigate growth hormone concentrations in patients with secondary liver malignancy.
    • To compare these concentrations with patients having primary malignancy or non-hepatic secondary malignancies.

    Main Methods:

    • Measurement of growth hormone concentrations in patient cohorts.
    • Comparison of GH levels across different malignancy groups (secondary liver, primary, non-hepatic secondary).

    Main Results:

    • Significantly higher growth hormone concentrations were observed in patients with secondary liver malignancy.

    Related Experiment Videos

  • Elevated GH levels were not specific to any particular type of tumor investigated.
  • GH concentrations in secondary liver malignancy patients were higher than in primary malignancy or non-hepatic secondary malignancy patients.

    • Conclusions:

    • Raised growth hormone concentrations are associated with secondary malignancy in the liver.
    • The findings suggest altered liver metabolism, rather than direct tumor production, is responsible for increased GH.
    • Further research into the mechanisms of altered hepatic metabolism in malignancy is warranted.